Jundishapur Journal of Microbiology

Published by: Kowsar

Oncogenic Virus Infections in the General Population and End-stage Renal Disease Patients With Special Emphasis on Kaposi’s Sarcoma Associated Herpes Virus (KSHV) in Northeast of Iran

Sanaz Ahmadi Ghezeldasht 1 , Tahereh Hassannia 2 , Houshang Rafatpanah 3 , Reza Hekmat 4 , Narges Valizadeh 3 , Majid Ghayour Mobarhan 1 and Seyed Abdolrahim Rezaee 1 , 5 , *
Authors Information
1 Research Center for HIV/AIDS, HTLV and Viral Hepatitis, Iranian Academic Center for Education, Culture and Research (ACECR), Mashhad Branch, Mashhad, IR Iran
2 Internal Medicine Department, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
3 Immunology Research Center, Buali Research Institute, Mashhad University of Medical Sciences, Mashhad, IR Iran
4 Nephrology Department, Mashhad University of Medical Sciences, Mashhad, IR Iran
5 Inflammation and Inflammatory Diseases Research Center, Medical School, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Jundishapur Journal of Microbiology: March 2015, 8 (3); e59821
  • Published Online: March 21, 2015
  • Article Type: Research Article
  • Received: September 19, 2013
  • Revised: December 14, 2013
  • Accepted: July 6, 2014
  • DOI: 10.5812/jjm.14920

To Cite: Ahmadi Ghezeldasht S, Hassannia T, Rafatpanah H, Hekmat R, Valizadeh N, et al. Oncogenic Virus Infections in the General Population and End-stage Renal Disease Patients With Special Emphasis on Kaposi’s Sarcoma Associated Herpes Virus (KSHV) in Northeast of Iran, Jundishapur J Microbiol. 2015 ; 8(3):e59821. doi: 10.5812/jjm.14920.

Abstract
Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127(12): 2893-917[DOI][PubMed]
  • 2. Adjei AA, Armah HB, Gbagbo F, Ampofo WK, Boamah I, Adu-Gyamfi C, et al. Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study. BMC Infect Dis. 2008; 8: 33[DOI][PubMed]
  • 3. Saha A, Kaul R, Murakami M, Robertson ES. Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention. Cancer Biol Ther. 2010; 10(10): 961-78[PubMed]
  • 4. Ahmadpoor P. Human herpesvirus-8 and Kaposi sarcoma after kidney transplantation: mechanisms of tumor genesis. Iran J Kidney Dis. 2009; 3(3): 121-6[PubMed]
  • 5. Allen UD. Human herpesvirus type 8 infections among solid organ transplant recipients. Pediatr Transplant. 2002; 6(3): 187-92[PubMed]
  • 6. Mendez JC, Paya CV. Kaposi's Sarcoma and Transplantation. Herpes. 2000; 7(1): 18-23[PubMed]
  • 7. Moore PS. The emergence of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). N Engl J Med. 2000; 343(19): 1411-3[DOI][PubMed]
  • 8. Plancoulaine S, Gessain A. [Epidemiological aspects of human herpesvirus 8 infection and of Kaposi's sarcoma]. Med Mal Infect. 2005; 35(5): 314-21[DOI][PubMed]
  • 9. Hjalgrim H, Melbye M, Pukkala E, Langmark F, Frisch M, Dictor M, et al. Epidemiology of Kaposi's sarcoma in the Nordic countries before the AIDS epidemic. Br J Cancer. 1996; 74(9): 1499-502[PubMed]
  • 10. Fickenscher H, Fleckenstein B. Herpesvirus saimiri. Philos Trans R Soc Lond B Biol Sci. 2001; 356(1408): 545-67[DOI][PubMed]
  • 11. Hanto DW. Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies. Annu Rev Med. 1995; 46: 381-94[DOI][PubMed]
  • 12. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012; 30(12): 2212-9[DOI][PubMed]
  • 13. Ahmad B, Ali S, Ali I, Azam S, Bashir S. Response rates of standard interferon therapy in chronic HCV patients of Khyber Pakhtunkhwa (KPK). Virol J. 2012; 9: 18[DOI][PubMed]
  • 14. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep. 2001; 50: 1-43[PubMed]
  • 15. Green MAR, Preiksaitis J. Guidelines for the prevention and management of infectious complications of solid organ transplantation. Am J Transplant. 2004; 4(10)
  • 16. Ahmadi Ghezeldasht S, Shirdel A, Assarehzadegan MA, Hassannia T, Rahimi H, Miri R, et al. Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL). Iran J Basic Med Sci. 2013; 16(3): 179-95[PubMed]
  • 17. Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, et al. High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol. 2011; 52(3): 172-6[DOI][PubMed]
  • 18. Azarpazhooh MR, Hasanpour K, Ghanbari M, Rezaee SA, Mashkani B, Hedayati-Moghaddam MR, et al. Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic analysis. AIDS Res Hum Retroviruses. 2012; 28(9): 1095-101[DOI][PubMed]
  • 19. Rezaee SA, Cunningham C, Davison AJ, Blackbourn DJ. Kaposi's sarcoma-associated herpesvirus immune modulation: an overview. J Gen Virol. 2006; 87: 1781-804[DOI][PubMed]
  • 20. Fathimoghaddam F, Hedayati-Moghaddam MR, Bidkhori HR, Ahmadi S, Sima HR. The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran. Hepat Mon. 2011; 11(5): 346-50[PubMed]
  • 21. Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer. 2009; 125(8): 1747-54[DOI][PubMed]
  • 22. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007; 370(9581): 59-67[DOI][PubMed]
  • 23. Cockfield SM, Preiksaitis JK, Jewell LD, Parfrey NA. Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center. Transplantation. 1993; 56(1): 88-96[PubMed]
  • 24. Cohen P. Infectious Diseases. 2003;
  • 25. Cattani P, Capuano M, Graffeo R, Ricci R, Cerimele F, Cerimele D, et al. Kaposi's sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients. J Clin Microbiol. 2001; 39(2): 506-8[DOI][PubMed]
  • 26. Moore PS, Chang Y. Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? Annu Rev Microbiol. 2003; 57: 609-39[DOI][PubMed]
  • 27. Marcelin AG, Calvez V, Dussaix E. KSHV after an organ transplant: should we screen? Curr Top Microbiol Immunol. 2007; 312: 245-62[PubMed]
  • 28. Einollahi B, Noorbala MM, Lessan Pezeshki M, Khatami MR, Simforoosh N, Firoozan A, et al. Incidence of postrenal transplantation malignancies: a report of two centers in Tehran, Iran. Transplant Proc. 2001; 33(5): 2812[PubMed]
  • 29. Qunibi W, Al-Furayh O, Almeshari K, Lin SF, Sun R, Heston L, et al. Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia. Transplantation. 1998; 65(4): 583-5[PubMed]
  • 30. Jalilvand S, Shoja Z, Mokhtari-Azad T, Nategh R, Gharehbaghian A. Seroprevalence of Human herpesvirus 8 (HHV-8) and incidence of Kaposi's sarcoma in Iran. Infect Agent Cancer. 2011; 6: 5[DOI][PubMed]
  • 31. Frances C, Mouquet C, Calvez V. Human herpesvirus 8 and renal transplantation. N Engl J Med. 1999; 340(13): 1045[DOI][PubMed]
  • 32. Bergallo M, Costa C, Margio S, Sidoti F, Re D, Segoloni GP, et al. Human herpes virus 8 infection in kidney transplant patients from an area of northwestern Italy (Piemonte region). Nephrol Dial Transplant. 2007; 22(6): 1757-61[DOI][PubMed]
  • 33. Rettig MB, Ma HJ, Vescio RA, Pold M, Schiller G, Belson D, et al. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science. 1997; 276(5320): 1851-4[PubMed]
  • 34. Wolf R, Brenner S, Ruocco V, Filioli FG. Isotopic response. Int J Dermatol. 1995; 34(5): 341-8[PubMed]
  • 35. Rosen HR. Hepatitis B and C in the liver transplant recipient: current understanding and treatment. Liver Transpl. 2001; 7(11 Suppl 1)-98[DOI][PubMed]
  • 36. Naghibi O, Nazemian F, Naghibi M, Ali Javidi DB. Prognosis of HTLV-1 positive renal transplant recipients in Iran. Saudi J Kidney Dis Transpl. 2011; 22(4): 670-4[PubMed]
  • 37. Brown RS. Hepatitis C and liver transplantation. Nature. 2005; 436(7053): 973-8[DOI][PubMed]
  • 38. Glicklich D, Thung SN, Kapoian T, Tellis V, Reinus JF. Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients. Am J Gastroenterol. 1999; 94(1): 159-63[DOI][PubMed]
  • 39. Fabrizi F, Lunghi G, Poordad FF, Martin P. Management of hepatitis B after renal transplantation: an update. J Nephrol. 2002; 15(2): 113-22[PubMed]
  • 40. Nakamura N, Tamaru S, Ohshima K, Tanaka M, Arakaki Y, Miyauchi T. Prognosis of HTLV-I-positive renal transplant recipients. Transplant Proc. 2005; 37(4): 1779-82[DOI][PubMed]
  • 41. Khameneh ZR, Sepehrvand N, Masudi S, Taghizade-Afshari A. Seroprevalence of HTLV-1 among kidney graft recipients: a single-center study. Exp Clin Transplant. 2010; 8(2): 146-9[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments